Abstract
Primary Aldosteronism (PA) is the most frequent cause of Endocrine Hypertension (HT), with an estimated prevalence of 20% among individuals with resistant HT. PA is associated with an increased risk of malignancy, probably due to aldosterone effects in promoting cell proliferation. Recently, a high prevalence of PA was demonstrated in patients with HT and Papillary Thyroid Cancer (PTC), s…